Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayuki Doi

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Atherosclerosis|February 18, 2014
Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery diseaseToru Miyoshi, Masayuki Doi, Shinichi Usui, et al.
International Journal of Cardiology|November 20, 2016
Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled studyKazumasa Nosaka, Toru Miyoshi, Mutsumi Iwamoto, et al.
International Journal of Cardiology|July 3, 2017
Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablationKeisuke Okawa, Toru Miyoshi, Saori Tsukuda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 1, 2006
Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in miceToru Miyoshi, Satoshi Hirohata, Hiroko Ogawa, et al.
Journal of Clinical Medicine|May 13, 2023
Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart FailureTomoaki Okada, Toru Miyoshi, Akihiro Oka, et al.
International Journal of Cardiology|February 19, 2017
Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trialToru Miyoshi, Kentaro Ejiri, Kunihisa Kohno, et al.
Cardiovascular Intervention and Therapeutics|November 13, 2020
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2Hirotoshi Watanabe, Takeshi Morimoto, Manabu Ogita, et al.
Journal of the American College of Cardiology|October 25, 2023
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary InterventionHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
JAMA|June 26, 2019
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical TrialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|February 23, 2020
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Atherosclerosis|February 18, 2014
Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery diseaseToru Miyoshi, Masayuki Doi, Shinichi Usui, et al.
International Journal of Cardiology|November 20, 2016
Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled studyKazumasa Nosaka, Toru Miyoshi, Mutsumi Iwamoto, et al.
International Journal of Cardiology|July 3, 2017
Differences in endothelial dysfunction induced by paroxysmal and persistent atrial fibrillation: Insights from restoration of sinus rhythm by catheter ablationKeisuke Okawa, Toru Miyoshi, Saori Tsukuda, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 1, 2006
Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in miceToru Miyoshi, Satoshi Hirohata, Hiroko Ogawa, et al.
Journal of Clinical Medicine|May 13, 2023
Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart FailureTomoaki Okada, Toru Miyoshi, Akihiro Oka, et al.
International Journal of Cardiology|February 19, 2017
Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: A randomized controlled trialToru Miyoshi, Kentaro Ejiri, Kunihisa Kohno, et al.
Cardiovascular Intervention and Therapeutics|November 13, 2020
Influence of CYP2C19 genotypes for the effect of 1-month dual antiplatelet therapy followed by clopidogrel monotherapy relative to 12-month dual antiplatelet therapy on clinical outcomes after percutaneous coronary intervention: a genetic substudy from the STOPDAPT-2Hirotoshi Watanabe, Takeshi Morimoto, Manabu Ogita, et al.
Journal of the American College of Cardiology|October 25, 2023
Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary InterventionHirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, et al.
JAMA|June 26, 2019
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical TrialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Cardiovascular Intervention and Therapeutics|February 23, 2020
Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trialHirotoshi Watanabe, Takenori Domei, Takeshi Morimoto, et al.
Pageof 6